Specific Metastatic Melanoma May Improve with IMO-2125, Yervoy ComboTagged Idera Pharmaceuticals, IMO-2125, Keytruda (pembrolizumab), PD-1 refractory metastatic melanoma, Yervoy (ipilimumab).Next:Study Finds Entrectinib Safe, Effective for Patients with Melanoma and Other Cancers
